These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 34976178)

  • 1. LncRNA EIF3J-AS1 functions as an oncogene by regulating MAFG to promote prostate cancer progression.
    Ye C; Qin S; Guo F; Yang Y; Wang H; Zhang C; Yang B
    J Cancer; 2022; 13(1):146-152. PubMed ID: 34976178
    [TBL] [Abstract][Full Text] [Related]  

  • 2. LncRNA MAFG-AS1 is involved in human cancer progression.
    Li P; Ma X; Gu X
    Eur J Med Res; 2023 Nov; 28(1):497. PubMed ID: 37941063
    [TBL] [Abstract][Full Text] [Related]  

  • 3. MAFG-AS1 aggravates the progression of pancreatic cancer by sponging miR-3196 to boost NFIX.
    Ye L; Feng W; Weng H; Yuan C; Liu J; Wang Z
    Cancer Cell Int; 2020 Dec; 20(1):591. PubMed ID: 33298078
    [TBL] [Abstract][Full Text] [Related]  

  • 4. MAFG-AS1 is a prognostic biomarker and facilitates prostate cancer progression.
    Li P; Shi Y; Guo M; Xu H; Zhan M; Wang Z; Chen Y
    Front Oncol; 2022; 12():856580. PubMed ID: 35992831
    [TBL] [Abstract][Full Text] [Related]  

  • 5. EIF3J-AS1 promotes glioma cell growth via up-regulating ANXA11 through sponging miR-1343-3p.
    Qi J; Wang Z; Zhao Z; Liu L
    Cancer Cell Int; 2020; 20():428. PubMed ID: 32905397
    [TBL] [Abstract][Full Text] [Related]  

  • 6. H3K27 acetylation-induced lncRNA EIF3J-AS1 improved proliferation and impeded apoptosis of colorectal cancer through miR-3163/YAP1 axis.
    Liu D; Zhang H; Cong J; Cui M; Ma M; Zhang F; Sun H; Chen C
    J Cell Biochem; 2020 Feb; 121(2):1923-1933. PubMed ID: 31709617
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Long noncoding RNA MAFG-AS1 promotes proliferation, migration and invasion of hepatocellular carcinoma cells through downregulation of miR-6852.
    Ouyang H; Zhang L; Xie Z; Ma S
    Exp Ther Med; 2019 Oct; 18(4):2547-2553. PubMed ID: 31572506
    [TBL] [Abstract][Full Text] [Related]  

  • 8. LncRNA MAFG-AS1 promotes the aggressiveness of breast carcinoma through regulating miR-339-5p/MMP15.
    Li H; Zhang GY; Pan CH; Zhang XY; Su XY
    Eur Rev Med Pharmacol Sci; 2019 Apr; 23(7):2838-2846. PubMed ID: 31002134
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A review on the roles and molecular mechanisms of MAFG-AS1 in oncogenesis.
    Dabbaghi KG; Mashatan N; Faraz O; Bashkandi AH; Shomoossi N; Tabnak P
    Pathol Res Pract; 2023 Mar; 243():154348. PubMed ID: 36736142
    [TBL] [Abstract][Full Text] [Related]  

  • 10. High-expression of LncRNA MAFG-AS1 is associated with the prognostic of patients with colorectal cancer.
    Cui W; Wang Y; Shen X; Wu X; Liu H; Xu X
    Rev Assoc Med Bras (1992); 2020 Nov; 66(11):1530-1535. PubMed ID: 33295405
    [TBL] [Abstract][Full Text] [Related]  

  • 11. LncRNA MAFG-AS1 Promotes the Progression of Bladder Cancer by Targeting the miR-143-3p/COX-2 Axis.
    Li D; Zhong S; Zhu Z; Jiang X; Zhang J; Gu J; Chen F
    Pathobiology; 2020; 87(6):345-355. PubMed ID: 33238264
    [TBL] [Abstract][Full Text] [Related]  

  • 12. LncRNA MAFG-AS1 boosts the proliferation of lung adenocarcinoma cells via regulating miR-744-5p/MAFG axis.
    Sui Y; Lin G; Zheng Y; Huang W
    Eur J Pharmacol; 2019 Sep; 859():172465. PubMed ID: 31211984
    [TBL] [Abstract][Full Text] [Related]  

  • 13. LncRNA MAFG-AS1 promotes the progression of colorectal cancer by sponging miR-147b and activation of NDUFA4.
    Cui S; Yang X; Zhang L; Zhao Y; Yan W
    Biochem Biophys Res Commun; 2018 Nov; 506(1):251-258. PubMed ID: 30348529
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Long Non-coding RNA MAFG-AS1 Promotes Cell Proliferation, Migration, and EMT by miR-3196/STRN4 in Drug-Resistant Cells of Liver Cancer.
    Chen T; Huang B; Pan Y
    Front Cell Dev Biol; 2021; 9():688603. PubMed ID: 34386494
    [TBL] [Abstract][Full Text] [Related]  

  • 15. HBx-upregulated MAFG-AS1 promotes cell proliferation and migration of hepatoma cells by enhancing MAFG expression and stabilizing nonmuscle myosin IIA.
    Zhang F; Li Y; Gan L; Tong X; Qi D; Wang Q; Ye X
    FASEB J; 2021 May; 35(5):e21529. PubMed ID: 33813778
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cross-talk between the ER pathway and the lncRNA MAFG-AS1/miR-339-5p/ CDK2 axis promotes progression of ER+ breast cancer and confers tamoxifen resistance.
    Feng J; Wen T; Li Z; Feng L; Zhou L; Yang Z; Xu L; Shi S; Hou K; Shen J; Han X; Teng Y
    Aging (Albany NY); 2020 Oct; 12(20):20658-20683. PubMed ID: 33098638
    [TBL] [Abstract][Full Text] [Related]  

  • 17. lncRNA MAFG-AS1 Contributes to Esophageal Squamous-Cell Carcinoma Progression via Regulating miR143/LASP1.
    Qu Y; Liu J
    Onco Targets Ther; 2020; 13():8359-8370. PubMed ID: 32903907
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Long non-coding RNA MAFG-AS1 promotes proliferation and metastasis of breast cancer by modulating STC2 pathway.
    Di S; Bai R; Lu D; Chen C; Ma T; Zou Z; Zhang Z
    Cell Death Discov; 2022 May; 8(1):249. PubMed ID: 35513366
    [TBL] [Abstract][Full Text] [Related]  

  • 19. LncRNA MAFG-AS1 regulates miR-125b-5p/SphK1 axis to promote the proliferation, migration, and invasion of bladder cancer cells.
    Tang C; Wu Y; Wang X; Chen K; Tang Z; Guo X
    Hum Cell; 2021 Mar; 34(2):588-597. PubMed ID: 33400245
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Long non-coding RNA MAFG-AS1 knockdown blocks malignant progression in breast cancer cells by inactivating JAK2/STAT3 signaling pathway via MAFG-AS1/miR-3196/TFAP2A axis.
    Ding M; Fu Y; Guo F; Chen H; Fu X; Tan W; Zhang H
    Int J Clin Exp Pathol; 2020; 13(10):2455-2473. PubMed ID: 33165437
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.